Madrid, February 1st 2016.– The Spanish Autonomous Regions’ debt on payments for medicine supplied to the NH hospitals dropped by approximately 30% with regards to the previous month. Payments made by the Regions’ Financing Fund through the Autonomous Liquidity Fund (FLA) and the Finance Facility Fund, have established the debt to be around 2,200 M€ at the end of 2015;  this is the most likely forecast, however is subject to  final consolidation.

Hence, all figures seem to indicate that 2015 closed its fiscal year with 13% less debt in the public hospital medicines market compared to 2014, which accounts for the best results seen since 2006 when debt sat at 2,142 M€, fixing the current figure in parameters that haven’t been registered since before the crisis.

Farmaindustria positively values this new dynamic which reduces the budgetary tensions on the companies that supply the Spanish National Health System, hoping that this trend is confirmed with new reductions of debt levels during the forthcoming months.